Related Experiment Video
Updated: Jun 4, 2026

Demonstrating a Linear Relationship Between Vascular Endothelial Growth Factor and Luteinizing Hormone in Kidney Cortex Extracts
Published on: January 22, 2020
Prohibitin as a novel target protein of luteinizing hormone in ovarian epithelial carcinogenesis
1Department of Obstetrics and Gynecology, Qilu Shandong University, Jinan 250012, China.
Abstract:
The exact role of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) in ovarian epithelial carcinoma (OEC) development has not been yet characterized. This prompted us to identify particular proteins to better understand the underlying mechanism. Total proteins from ovarian epithelial tumor (OET) cells treated with gonadotropins were analyzed by proteomics. Western blot and immunohistochemistry were used to validate the target protein (prohibitin) and to detect its expression in human ovarian tissue of serous tumors. As the results, prohibitin was found to be significantly up-regulated by LH, with a maximum of 2.5-fold increase at the concentration of 200 mIU/mL. The expression of prohibitin was steadily decreased from benign serous cystadenomas to borderline tumors and serous carcinomas (P < 0.0001). The difference between any two groups was significant (P < 0.001). Collectively, data from this study indicate that prohibitin is one LH-associated protein and it may be protective of ovarian cancer development and progression, supporting that LH may play an inhibitory role in ovarian tumorigenesis.
Insights
Luteinizing hormone (LH) up-regulates prohibitin, a protein that decreases with ovarian cancer progression. This suggests LH may inhibit ovarian cancer development and progression.
Area of Science:
- Endocrinology
- Oncology
- Proteomics
Background:
- The roles of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) in ovarian epithelial carcinoma (OEC) remain unclear.
- Understanding the molecular mechanisms underlying OEC development is crucial for targeted therapies.
Purpose of the Study:
- To investigate the relationship between gonadotropins and specific proteins in ovarian epithelial tumor (OET) cells.
- To identify proteins modulated by LH and FSH and their potential role in OEC pathogenesis.
Main Methods:
- Proteomic analysis of OET cells treated with gonadotropins.
- Validation of prohibitin as a target protein using Western blot.
- Immunohistochemical detection of prohibitin expression in human serous ovarian tumors.
Main Results:
- LH significantly up-regulated prohibitin expression in OET cells (up to 2.5-fold at 200 mIU/mL).
- Prohibitin expression decreased progressively from benign serous cystadenomas to borderline tumors and serous carcinomas (P < 0.0001).
- Significant differences in prohibitin expression were observed between all tumor groups (P < 0.001).
Conclusions:
- Prohibitin is an LH-associated protein potentially involved in ovarian cancer.
- LH may exert a protective effect against ovarian cancer development and progression.
- LH might play an inhibitory role in ovarian tumorigenesis.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Abnormal Proliferation
Inhibitors of Viral Protein Synthesis
